Profiling the Tox21 Chemical Collection for Acetylcholinesterase Inhibition.
Journal
Environmental health perspectives
ISSN: 1552-9924
Titre abrégé: Environ Health Perspect
Pays: United States
ID NLM: 0330411
Informations de publication
Date de publication:
04 2021
04 2021
Historique:
entrez:
12
4
2021
pubmed:
13
4
2021
medline:
26
11
2021
Statut:
ppublish
Résumé
Inhibition of acetylcholinesterase (AChE), a biomarker of organophosphorous and carbamate exposure in environmental and occupational human health, has been commonly used to identify potential safety liabilities. So far, many environmental chemicals, including drug candidates, food additives, and industrial chemicals, have not been thoroughly evaluated for their inhibitory effects on AChE activity. AChE inhibitors can have therapeutic applications (e.g., tacrine and donepezil) or neurotoxic consequences (e.g., insecticides and nerve agents). The objective of the current study was to identify environmental chemicals that inhibit AChE activity using To identify AChE inhibitors rapidly and efficiently, we have screened the Toxicology in the 21st Century (Tox21) 10K compound library in a quantitative high-throughput screening (qHTS) platform by using the homogenous cell-based AChE inhibition assay and enzyme-based AChE inhibition assays (with or without microsomes). AChE inhibitors identified from the primary screening were further tested in monolayer or spheroid formed by SH-SY5Y and neural stem cell models. The inhibition and binding modes of these identified compounds were studied with time-dependent enzyme-based AChE inhibition assay and molecular docking, respectively. A group of known AChE inhibitors, such as donepezil, ambenonium dichloride, and tacrine hydrochloride, as well as many previously unreported AChE inhibitors, such as chelerythrine chloride and cilostazol, were identified in this study. Many of these compounds, such as pyrazophos, phosalone, and triazophos, needed metabolic activation. This study identified both reversible (e.g., donepezil and tacrine) and irreversible inhibitors (e.g., chlorpyrifos and bromophos-ethyl). Molecular docking analyses were performed to explain the relative inhibitory potency of selected compounds. Our tiered qHTS approach allowed us to generate a robust and reliable data set to evaluate large sets of environmental compounds for their AChE inhibitory activity. https://doi.org/10.1289/EHP6993.
Sections du résumé
BACKGROUND
Inhibition of acetylcholinesterase (AChE), a biomarker of organophosphorous and carbamate exposure in environmental and occupational human health, has been commonly used to identify potential safety liabilities. So far, many environmental chemicals, including drug candidates, food additives, and industrial chemicals, have not been thoroughly evaluated for their inhibitory effects on AChE activity. AChE inhibitors can have therapeutic applications (e.g., tacrine and donepezil) or neurotoxic consequences (e.g., insecticides and nerve agents).
OBJECTIVES
The objective of the current study was to identify environmental chemicals that inhibit AChE activity using
METHODS
To identify AChE inhibitors rapidly and efficiently, we have screened the Toxicology in the 21st Century (Tox21) 10K compound library in a quantitative high-throughput screening (qHTS) platform by using the homogenous cell-based AChE inhibition assay and enzyme-based AChE inhibition assays (with or without microsomes). AChE inhibitors identified from the primary screening were further tested in monolayer or spheroid formed by SH-SY5Y and neural stem cell models. The inhibition and binding modes of these identified compounds were studied with time-dependent enzyme-based AChE inhibition assay and molecular docking, respectively.
RESULTS
A group of known AChE inhibitors, such as donepezil, ambenonium dichloride, and tacrine hydrochloride, as well as many previously unreported AChE inhibitors, such as chelerythrine chloride and cilostazol, were identified in this study. Many of these compounds, such as pyrazophos, phosalone, and triazophos, needed metabolic activation. This study identified both reversible (e.g., donepezil and tacrine) and irreversible inhibitors (e.g., chlorpyrifos and bromophos-ethyl). Molecular docking analyses were performed to explain the relative inhibitory potency of selected compounds.
CONCLUSIONS
Our tiered qHTS approach allowed us to generate a robust and reliable data set to evaluate large sets of environmental compounds for their AChE inhibitory activity. https://doi.org/10.1289/EHP6993.
Identifiants
pubmed: 33844597
doi: 10.1289/EHP6993
pmc: PMC8041433
doi:
Substances chimiques
Cholinesterase Inhibitors
0
Insecticides
0
Acetylcholinesterase
EC 3.1.1.7
Types de publication
Journal Article
Research Support, N.I.H., Intramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
47008Références
Eur J Neurosci. 2010 Apr;31(7):1185-93
pubmed: 20345925
Toxicol Appl Pharmacol. 2017 Oct 15;333:68-75
pubmed: 28830837
J Comput Chem. 2012 Dec 5;33(31):2451-68
pubmed: 22821581
Carcinogenesis. 2006 Mar;27(3):429-36
pubmed: 16272577
Phytomedicine. 2007 Apr;14(4):289-300
pubmed: 17346955
Neural Netw. 2006 Jul-Aug;19(6-7):723-33
pubmed: 16774731
Pharmacotherapy. 2000 Mar;20(3):270-9
pubmed: 10730683
J Chem Theory Comput. 2008 Mar;4(3):435-47
pubmed: 26620784
Risk Anal. 2009 Apr;29(4):474-9
pubmed: 19144067
Gen Physiol Biophys. 2007 Dec;26(4):247-53
pubmed: 18281741
Biotechnol J. 2017 May;12(5):
pubmed: 28294544
Prog Neurobiol. 1993 Jul;41(1):31-91
pubmed: 8321908
Chem Biol Interact. 2010 Sep 6;187(1-3):325-9
pubmed: 20211614
Methods Mol Biol. 2016;1473:111-22
pubmed: 27518629
Ann Palliat Med. 2012 Jul;1(2):137-42
pubmed: 25841474
Nat Rev Drug Discov. 2012 Dec;11(12):909-22
pubmed: 23197038
J Comput Chem. 2010 Mar;31(4):671-90
pubmed: 19575467
J Chem Inf Model. 2015 Mar 23;55(3):700-8
pubmed: 25692383
Toxicol Lett. 2010 Mar 1;193(1):9-18
pubmed: 19948211
Food Chem Toxicol. 1994 Aug;32(8):763-7
pubmed: 7520881
ALTEX. 2018 Mar 8;35(2):163-168
pubmed: 29529324
Biomed Pharmacother. 2018 Feb;98:297-307
pubmed: 29274586
J Mol Neurosci. 2006;30(1-2):51-4
pubmed: 17192624
PLoS Comput Biol. 2009 Jul;5(7):e1000435
pubmed: 19593374
Environ Health Perspect. 2011 Jun;119(6):801-6
pubmed: 21224175
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2011 Sep;155(3):219-29
pubmed: 22286807
Cell Discov. 2015 Apr 28;1:15002
pubmed: 27462404
J Med Chem. 2008 Jul 24;51(14):4200-12
pubmed: 18570368
Chem Res Toxicol. 2021 Feb 15;34(2):189-216
pubmed: 33140634
J Toxicol Environ Health. 1994 Nov;43(3):271-89
pubmed: 7966438
J Med Toxicol. 2018 Sep;14(3):237-241
pubmed: 29907949
Proc Natl Acad Sci U S A. 2006 Aug 1;103(31):11473-8
pubmed: 16864780
Invest Ophthalmol Vis Sci. 2013 May 03;54(5):3171-83
pubmed: 23599333
Science. 1970 Sep 18;169(3951):1213-4
pubmed: 4317923
Clin Chim Acta. 2009 Apr;402(1-2):114-8
pubmed: 19185568
Chem Res Toxicol. 2008 Feb;21(2):421-31
pubmed: 18163544
J Chem Inf Model. 2013 Dec 23;53(12):3384-98
pubmed: 24245913
Drug Metab Dispos. 2005 Mar;33(3):295-302
pubmed: 15557345
Obes Rev. 2018 Feb;19(2):269-280
pubmed: 29024348
Curr Neuropharmacol. 2013 May;11(3):315-35
pubmed: 24179466
Environ Health Perspect. 2013 May;121(5):619-24
pubmed: 23359481
Environ Health Perspect. 2011 Aug;119(8):1142-8
pubmed: 21543282
J Pharmacol Exp Ther. 1988 Dec;247(3):1093-102
pubmed: 2905002
Arch Biochem Biophys. 2018 Oct 1;655:67-74
pubmed: 30098983
Methods Mol Biol. 2016;1473:123-34
pubmed: 27518630
J Chem Inf Model. 2019 Jun 24;59(6):3018-3035
pubmed: 31034213
Nat Rev Neurosci. 2001 Apr;2(4):294-302
pubmed: 11283752
Aliment Pharmacol Ther. 2004 Feb 15;19(4):379-90
pubmed: 14871277
Curr Chem Genomics. 2010 Oct 21;4:57-66
pubmed: 21331310
Int J Mol Sci. 2018 Oct 28;19(11):
pubmed: 30373287
Drug Discov Today. 2013 Aug;18(15-16):716-23
pubmed: 23732176
Mol Psychiatry. 2002;7(3):247-53
pubmed: 11920152
Environ Health Perspect. 1990 Jul;87:245-54
pubmed: 2176588
Int J Obes (Lond). 2014 May;38(5):689-97
pubmed: 23942319
BMC Cancer. 2015 May 10;15:385
pubmed: 25956553
Proc Soc Exp Biol Med. 1971 May;137(1):357-60
pubmed: 5581674
Environ Health Perspect. 2013 Jul;121(7):756-65
pubmed: 23603828
Nat Commun. 2016 Jan 26;7:10425
pubmed: 26811972
Hepatology. 2011 Feb;53(2):493-503
pubmed: 21274871
Toxicol In Vitro. 2019 Apr;56:93-100
pubmed: 30625376
J Am Chem Soc. 2011 Feb 9;133(5):1553-62
pubmed: 21222447
Nat Methods. 2017 Jan;14(1):71-73
pubmed: 27819658